FFPRHC Guidance (April 2004). The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health.
D000282:Administration, Intravaginal; D000328:Adult; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000627:therapeutic use*; D000075202:Contraindications; D003376:Counseling / Q000592:standards; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D007435:Intrauterine Devices, Copper / Q000009:adverse effects / Q000592:standards*; D016912:Levonorgestrel / Q000008:administration & dosage / Q000627:therapeutic use*; D008595:Menorrhagia / Q000188:drug therapy*; D034121:Reproductive Health Services / Q000592:standards*; D014944:World Health Organization
D003271:Contraceptive Agents, Female; D016912:Levonorgestrel